age at least 18 Years
Item
age at least 18 Years
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Signed and dated informed consent.
Item
Signed and dated informed consent.
boolean
C1519316 (UMLS CUI 2011AA)
C0011008 (UMLS CUI 2011AA)
410671006 (SNOMED CT 2011_0131)
MTHU021546 (LOINC Version 232)
C0021430 (UMLS CUI 2011AA)
Patients with the typical presentation of HLA-B27 positive AAU (unilateral, painful anterior uveitis of sudden onset).
Item
Patients with the typical presentation of HLA-B27 positive AAU (unilateral, painful anterior uveitis of sudden onset).
boolean
C0019740 (UMLS CUI 2011AA)
34453005 (SNOMED CT 2011_0131)
MTHU012533 (LOINC Version 232)
CL415097 (UMLS CUI 2011AA)
C0701807 (UMLS CUI 2011AA)
4927003 (SNOMED CT 2011_0131)
H20.0 (ICD-10-CM Version 2010)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0205092 (UMLS CUI 2011AA)
66459002 (SNOMED CT 2011_0131)
CL414713 (UMLS CUI 2011AA)
C0042165 (UMLS CUI 2011AA)
410692006 (SNOMED CT 2011_0131)
10046852 (MedDRA 14.1)
C1272517 (UMLS CUI 2011AA)
385315009 (SNOMED CT 2011_0131)
2+ anterior chamber cells according to the SUN Working Group criteria, as assessed by slit lamp biomicroscopy.
Item
2+ anterior chamber cells according to the SUN Working Group criteria, as assessed by slit lamp biomicroscopy.
boolean
C2827735 (UMLS CUI 2011AA)
C0423282 (UMLS CUI 2011AA)
246993000 (SNOMED CT 2011_0131)
10053781 (MedDRA 14.1)
C0332290 (UMLS CUI 2011AA)
385433004 (SNOMED CT 2011_0131)
C0038136 (UMLS CUI 2011AA)
C0042164 (UMLS CUI 2011AA)
128473001 (SNOMED CT 2011_0131)
10046851 (MedDRA 14.1)
H20.9 (ICD-10-CM Version 2010)
E10442 (CTCAE 1105E)
C0600281 (UMLS CUI 2011AA)
CL414621 (UMLS CUI 2011AA)
C0582103 (UMLS CUI 2011AA)
225886003 (SNOMED CT 2011_0131)
C0183355 (UMLS CUI 2011AA)
397247004 (SNOMED CT 2011_0131)
Start of the typical first symptoms of the current attack, defined as the point in time when the patient felt the first sensation of the attack, within the last 72 hours before initiation of treatment with the study medication.
Item
Start of the typical first symptoms of the current attack, defined as the point in time when the patient felt the first sensation of the attack, within the last 72 hours before initiation of treatment with the study medication.
boolean
C0205435 (UMLS CUI 2011AA)
255216001 (SNOMED CT 2011_0131)
C1457887 (UMLS CUI 2011AA)
MTHU021540 (LOINC Version 232)
780-789.99 (ICD-9-CM Version 2011)
C1304680 (UMLS CUI 2011AA)
216299002 (SNOMED CT 2011_0131)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C2348558 (UMLS CUI 2011AA)
C0013227 (UMLS CUI 2011AA)
Negative pregnancy test for females of childbearing potential (pre menopausal, <2 years post-menopausal, not surgically sterile).
Item
Negative pregnancy test for females of childbearing potential (pre menopausal, <2 years post-menopausal, not surgically sterile).
boolean
C0427780 (UMLS CUI 2011AA)
250425007 (SNOMED CT 2011_0131)
10036574 (MedDRA 14.1)
C0015780 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C0279752 (UMLS CUI 2011AA)
C0232970 (UMLS CUI 2011AA)
76498008 (SNOMED CT 2011_0131)
Patients with a negative QuantiFERON TB Gold test result.
Item
Patients with a negative QuantiFERON TB Gold test result.
boolean
C1875713 (UMLS CUI 2011AA)
C1334932 (UMLS CUI 2011AA)
Patients who currently have no clinically apparent symptoms of an HLA B27 associated acute extraocular disorder requiring systemic immunosuppressive therapy.
Item
Patients who currently have no clinically apparent symptoms of an HLA B27 associated acute extraocular disorder requiring systemic immunosuppressive therapy.
boolean
C1518422 (UMLS CUI 2011AA)
C0019740 (UMLS CUI 2011AA)
34453005 (SNOMED CT 2011_0131)
MTHU012533 (LOINC Version 232)
C0332281 (UMLS CUI 2011AA)
47429007 (SNOMED CT 2011_0131)
C0241886 (UMLS CUI 2011AA)
C0012634 (UMLS CUI 2011AA)
64572001 (SNOMED CT 2011_0131)
C1514873 (UMLS CUI 2011AA)
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C0021079 (UMLS CUI 2011AA)
86553008 (SNOMED CT 2011_0131)
Patients who are willing and able to cooperate with study requirements.
Item
Patients who are willing and able to cooperate with study requirements.
boolean
C0600109 (UMLS CUI 2011AA)
225466006 (SNOMED CT 2011_0131)
C0085732 (UMLS CUI 2011AA)
371150009 (SNOMED CT 2011_0131)
C0392337 (UMLS CUI 2011AA)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C1514873 (UMLS CUI 2011AA)
IOP elevation requiring therapy.
Item
IOP elevation requiring therapy.
boolean
C0234708 (UMLS CUI 2011AA)
112222000 (SNOMED CT 2011_0131)
10022806 (MedDRA 14.1)
C1514873 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
Uncontrolled diabetes mellitus and diabetic retinopathy.
Item
Uncontrolled diabetes mellitus and diabetic retinopathy.
boolean
C0205318 (UMLS CUI 2011AA)
19032002 (SNOMED CT 2011_0131)
C0011849 (UMLS CUI 2011AA)
191044006 (SNOMED CT 2011_0131)
C0011884 (UMLS CUI 2011AA)
4855003 (SNOMED CT 2011_0131)
10012689 (MedDRA 14.1)
MTHU020818 (LOINC Version 232)
362.0 (ICD-9-CM Version 2011)
Patients with a single eye or a pinhole Snellen visual acuity 20/200 or worse in the non study eye.
Item
Patients with a single eye or a pinhole Snellen visual acuity 20/200 or worse in the non study eye.
boolean
C0205171 (UMLS CUI 2011AA)
50607009 (SNOMED CT 2011_0131)
C0015392 (UMLS CUI 2011AA)
81745001 (SNOMED CT 2011_0131)
MTHU000064 (LOINC Version 232)
C0450042 (UMLS CUI 2011AA)
257492003 (SNOMED CT 2011_0131)
C1827708 (UMLS CUI 2011AA)
422673001 (SNOMED CT 2011_0131)
C1518422 (UMLS CUI 2011AA)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C0015392 (UMLS CUI 2011AA)
81745001 (SNOMED CT 2011_0131)
MTHU000064 (LOINC Version 232)
Patients with <= 1+ anterior chamber cells.
Item
<= 1+ Anterior chamber cells (finding)
boolean
C0423282 (UMLS CUI 2011AA)
246993000 (SNOMED CT 2011_0131)
10053781 (MedDRA 14.1)
Patients with 3+ or 4+ anterior chamber cells or hypopyon.
Item
Patients with 3+ or 4+ anterior chamber cells or hypopyon.
boolean
C2827736 (UMLS CUI 2011AA)
C2827737 (UMLS CUI 2011AA)
C0423282 (UMLS CUI 2011AA)
246993000 (SNOMED CT 2011_0131)
10053781 (MedDRA 14.1)
C0020641 (UMLS CUI 2011AA)
87807004 (SNOMED CT 2011_0131)
10021086 (MedDRA 14.1)
H20.05 (ICD-10-CM Version 2010)
364.05 (ICD-9-CM Version 2011)
Patients in whom the time of the beginning of the current attack can not be determined.
Item
Patients in whom the time of the beginning of the current attack can not be determined.
boolean
C0439547 (UMLS CUI 2011AA)
272105005 (SNOMED CT 2011_0131)
C0439659 (UMLS CUI 2011AA)
246062003 (SNOMED CT 2011_0131)
MTHU026300 (LOINC Version 232)
C0521116 (UMLS CUI 2011AA)
15240007 (SNOMED CT 2011_0131)
C1304680 (UMLS CUI 2011AA)
216299002 (SNOMED CT 2011_0131)
C0439673 (UMLS CUI 2011AA)
261665006 (SNOMED CT 2011_0131)
Patients exhibiting corneal ulceration or a history of recurrent herpetic keratitis or clinical evidence of herpetic dermatitis.
Item
Patients exhibiting corneal ulceration or a history of recurrent herpetic keratitis or clinical evidence of herpetic dermatitis.
boolean
C0010043 (UMLS CUI 2011AA)
91514001 (SNOMED CT 2011_0131)
10011060 (MedDRA 14.1)
H16.0 (ICD-10-CM Version 2010)
370.0 (ICD-9-CM Version 2011)
E10359 (CTCAE 1105E)
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C1274320 (UMLS CUI 2011AA)
402891002 (SNOMED CT 2011_0131)
C0332120 (UMLS CUI 2011AA)
18669006 (SNOMED CT 2011_0131)
C1262170 (UMLS CUI 2011AA)
10062639 (MedDRA 14.1)
Patients currently treated with topical corticosteroids.
Item
Patients currently treated with topical corticosteroids.
boolean
C2827774 (UMLS CUI 2011AA)
C0304604 (UMLS CUI 2011AA)
331645009 (SNOMED CT 2011_0131)
Patients treated with systemic immunosuppressive therapy within the last 2 months.
Item
Patients treated with systemic immunosuppressive therapy within the last 2 months.
boolean
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C0021079 (UMLS CUI 2011AA)
86553008 (SNOMED CT 2011_0131)
Patients treated with a systemically administered TNF-alpha inhibitor within the last 2 months.
Item
Patients treated with a systemically administered TNF-alpha inhibitor within the last 2 months.
boolean
C0205373 (UMLS CUI 2011AA)
31099001 (SNOMED CT 2011_0131)
C1521801 (UMLS CUI 2011AA)
C1562242 (UMLS CUI 2011AA)
416897008 (SNOMED CT 2011_0131)
Pregnant or breast-feeding women or women of childbearing potential, who with their partners refuse to use 2 reliable methods of contraception (including 1 barrier method) during the study.
Item
Pregnant or breast-feeding women or women of childbearing potential, who with their partners refuse to use 2 reliable methods of contraception (including 1 barrier method) during the study.
boolean
C0043210 (UMLS CUI 2011AA)
224526002 (SNOMED CT 2011_0131)
C0032961 (UMLS CUI 2011AA)
289908002 (SNOMED CT 2011_0131)
10036556 (MedDRA 14.1)
MTHU035048 (LOINC Version 232)
C0006147 (UMLS CUI 2011AA)
10006247 (MedDRA 14.1)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C0682323 (UMLS CUI 2011AA)
262043009 (SNOMED CT 2011_0131)
SIGOTHR (HL7 V3 2006_05)
C2733540 (UMLS CUI 2011AA)
443390004 (SNOMED CT 2011_0131)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
C0004764 (UMLS CUI 2011AA)
225370004 (SNOMED CT 2011_0131)
Male patients with a female partner who could become pregnant and who refuse, with their partner, to use 2 reliable methods of contraception (including 1 barrier method) during the study.
Item
Male patients with a female partner who could become pregnant and who refuse, with their partner, to use 2 reliable methods of contraception (including 1 barrier method) during the study.
boolean
C0024554 (UMLS CUI 2011AA)
248153007 (SNOMED CT 2011_0131)
M (HL7 V3 2006_05)
C0015780 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
C0682323 (UMLS CUI 2011AA)
262043009 (SNOMED CT 2011_0131)
SIGOTHR (HL7 V3 2006_05)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C2733540 (UMLS CUI 2011AA)
443390004 (SNOMED CT 2011_0131)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
C0004764 (UMLS CUI 2011AA)
225370004 (SNOMED CT 2011_0131)
Patients whose clinical presentation is suggestive for an active bacterial, viral or fungal infection anywhere in the body.
Item
Patients whose clinical presentation is suggestive for an active bacterial, viral or fungal infection anywhere in the body.
boolean
C0750491 (UMLS CUI 2011AA)
415684004 (SNOMED CT 2011_0131)
C0004623 (UMLS CUI 2011AA)
87628006 (SNOMED CT 2011_0131)
10060945 (MedDRA 14.1)
A49.9 (ICD-10-CM Version 2010)
C0042769 (UMLS CUI 2011AA)
34014006 (SNOMED CT 2011_0131)
10047461 (MedDRA 14.1)
B34.9 (ICD-10-CM Version 2010)
C0026946 (UMLS CUI 2011AA)
3218000 (SNOMED CT 2011_0131)
10017533 (MedDRA 14.1)
B35-B49 (ICD-10-CM Version 2010)
110-118.99 (ICD-9-CM Version 2011)
Patients with history of recurrent infections, or a clinical presentation suggestive of a chronic infection requiring antimicrobial therapy (e.g. syphilis) including active episodes of serious viral infections by, e.g. herpes simplex, herpes zoster, cytomegalic or hepatitis viruses or clinical signs of fungal infections, such as histoplasmosis, aspergillosis or coccidiomycosis.
Item
Patients with history of recurrent infections, or a clinical presentation suggestive of a chronic infection requiring antimicrobial therapy (e.g. syphilis) including active episodes of serious viral infections by, e.g. herpes simplex, herpes zoster, cytomegalic or hepatitis viruses or clinical signs of fungal infections, such as histoplasmosis, aspergillosis or coccidiomycosis.
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0239998 (UMLS CUI 2011AA)
10067860 (MedDRA 14.1)
C0750491 (UMLS CUI 2011AA)
415684004 (SNOMED CT 2011_0131)
C0151317 (UMLS CUI 2011AA)
177010002 (SNOMED CT 2011_0131)
C1514873 (UMLS CUI 2011AA)
C1136254 (UMLS CUI 2011AA)
250428009 (SNOMED CT 2011_0131)
MTHU014499 (LOINC Version 232)
C0039128 (UMLS CUI 2011AA)
76272004 (SNOMED CT 2011_0131)
10062120 (MedDRA 14.1)
A53.9 (ICD-10-CM Version 2010)
097.9 (ICD-9-CM Version 2011)
C0019348 (UMLS CUI 2011AA)
88594005 (SNOMED CT 2011_0131)
10019948 (MedDRA 14.1)
B00 (ICD-10-CM Version 2010)
054 (ICD-9-CM Version 2011)
C0019360 (UMLS CUI 2011AA)
4740000 (SNOMED CT 2011_0131)
10019974 (MedDRA 14.1)
B02 (ICD-10-CM Version 2010)
53 (ICD-9-CM Version 2011)
C0010825 (UMLS CUI 2011AA)
407444007 (SNOMED CT 2011_0131)
10009701 (MedDRA 14.1)
MTHU033986 (LOINC Version 232)
C0019186 (UMLS CUI 2011AA)
C0019655 (UMLS CUI 2011AA)
12962009 (SNOMED CT 2011_0131)
10020141 (MedDRA 14.1)
B39.9 (ICD-10-CM Version 2010)
115.90 (ICD-9-CM Version 2011)
C0004030 (UMLS CUI 2011AA)
65553006 (SNOMED CT 2011_0131)
10003488 (MedDRA 14.1)
B44 (ICD-10-CM Version 2010)
117.3 (ICD-9-CM Version 2011)
C0262426 (UMLS CUI 2011AA)
Patients presenting with higher intraocular pressure in the uveitic eye than in the contralateral eye.
Item
Patients presenting with higher intraocular pressure in the uveitic eye than in the contralateral eye.
boolean
C0578862 (UMLS CUI 2011AA)
302157000 (SNOMED CT 2011_0131)
C0042164 (UMLS CUI 2011AA)
128473001 (SNOMED CT 2011_0131)
10046851 (MedDRA 14.1)
H20.9 (ICD-10-CM Version 2010)
E10442 (CTCAE 1105E)
C0015392 (UMLS CUI 2011AA)
81745001 (SNOMED CT 2011_0131)
MTHU000064 (LOINC Version 232)
C0439093 (UMLS CUI 2011AA)
276140008 (SNOMED CT 2011_0131)
GT (HL7 V3 2006_05)
C0441988 (UMLS CUI 2011AA)
255209002 (SNOMED CT 2011_0131)
C0015392 (UMLS CUI 2011AA)
81745001 (SNOMED CT 2011_0131)
MTHU000064 (LOINC Version 232)
Patients with known carrier status of human immunodeficiency virus, hepatitis B or hepatitis C.
Item
Patients with known carrier status of human immunodeficiency virus, hepatitis B or hepatitis C.
boolean
C0449439 (UMLS CUI 2011AA)
246098006 (SNOMED CT 2011_0131)
C0019682 (UMLS CUI 2011AA)
19030005 (SNOMED CT 2011_0131)
C0019163 (UMLS CUI 2011AA)
66071002 (SNOMED CT 2011_0131)
10019731 (MedDRA 14.1)
C0019196 (UMLS CUI 2011AA)
50711007 (SNOMED CT 2011_0131)
10019744 (MedDRA 14.1)
B19.20 (ICD-10-CM Version 2010)
070.7 (ICD-9-CM Version 2011)
Patients with a history of demyelinating disease (multiple sclerosis) or optic neuritis.
Item
Patients with a history of demyelinating disease (multiple sclerosis) or optic neuritis.
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0011304 (UMLS CUI 2011AA)
32693004 (SNOMED CT 2011_0131)
10012305 (MedDRA 14.1)
C0026769 (UMLS CUI 2011AA)
24700007 (SNOMED CT 2011_0131)
10028245 (MedDRA 14.1)
MTHU020805 (LOINC Version 232)
G35 (ICD-10-CM Version 2010)
340 (ICD-9-CM Version 2011)
C0029134 (UMLS CUI 2011AA)
66760008 (SNOMED CT 2011_0131)
10030942 (MedDRA 14.1)
H46.9 (ICD-10-CM Version 2010)
377.30 (ICD-9-CM Version 2011)
Patients with positive or unclear QuantiFERON TB Gold test result or history of high risk exposure to Mycobacterium tuberculosis.
Item
Patients with positive or unclear QuantiFERON TB Gold test result or history of high risk exposure to Mycobacterium tuberculosis.
boolean
C1875713 (UMLS CUI 2011AA)
C1335447 (UMLS CUI 2011AA)
CL427836 (UMLS CUI 2011AA)
C0587081 (UMLS CUI 2011AA)
118246004 (SNOMED CT 2011_0131)
C0332167 (UMLS CUI 2011AA)
15508007 (SNOMED CT 2011_0131)
C2732789 (UMLS CUI 2011AA)
444507004 (SNOMED CT 2011_0131)
Patients with known coexisting malignancy.
Item
Patients with known coexisting malignancy.
boolean
CL415222 (UMLS CUI 2011AA)
C0006826 (UMLS CUI 2011AA)
363346000 (SNOMED CT 2011_0131)
10028997 (MedDRA 14.1)
MTHU010328 (LOINC Version 232)
C00-C96 (ICD-10-CM Version 2010)